Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design (original) (raw)

Percutaneous closure of patent foramen ovale in cryptogenic embolism

Bindu Kalesan

The New England journal of medicine, 2013

View PDFchevron_right

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline

Elke Hoendermis

BMJ (Clinical research ed.), 2018

View PDFchevron_right

Long-Term Propensity Score-Matched Comparison of Percutaneous Closure of Patent Foramen Ovale With Medical Treatment After Paradoxical Embolism

Peter Juni

Circulation, 2012

View PDFchevron_right

Management of patients with patent foramen ovale and cryptogenic stroke

gian paolo anzola

Catheterization and Cardiovascular Interventions, 2013

View PDFchevron_right

Patent Foramen Ovale and Cryptogenic Stroke: Challenges in Diagnosis and Management

ali yafi

Indonesian Journal of Cardiology

View PDFchevron_right

Patent foramen ovale closure and medical therapy for cryptogenic stroke evidence from randomized

Fortune Journals

View PDFchevron_right

Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited

Cesare Baldi

Journal of Clinical Medicine Research, 2016

View PDFchevron_right

A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events

Robert Sommer

Catheterization and Cardiovascular Interventions, 2013

View PDFchevron_right

Percutaneous Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism Long-Term Risk of Recurrent Thromboembolic Events

Bernhard Meier

2000

View PDFchevron_right

Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia

Alessandro Giardini

American Journal of Cardiology, 2004

View PDFchevron_right

Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale

Laura Vaskelyte

European Heart Journal, 2013

View PDFchevron_right

Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale

Andrea Berghold

International Journal of Cardiology, 2005

View PDFchevron_right

Prevention of recurrent cryptogenic stroke with percutaneous closure of patent foramen ovale; one year follow-up study with magnetic resonance imaging and Holter monitoring

Giray Kabakcı

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2015

View PDFchevron_right

Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke

Yeong-bae Lee

Journal of interventional cardiology, 2017

View PDFchevron_right

Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials

ludmilla mantione

International journal of cardiology, 2018

View PDFchevron_right

Cryptogenic Stroke and High-Risk Patent Foramen Ovale

Pil hyung Lee

Journal of the American College of Cardiology, 2018

View PDFchevron_right

Propensity Score–Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale

Valeria De Giuli

Circulation: Cardiovascular Interventions, 2016

View PDFchevron_right

Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome

Catherine Lambert

Journal of Interventional Cardiology

View PDFchevron_right

Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke

Bernhard Meier

Journal of the American …, 2004

View PDFchevron_right

Patent Foramen Ovale Closure in the Setting of Cryptogenic Stroke: A Meta-Analysis of Five Randomized Trials

mahek shah

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018

View PDFchevron_right

Percutaneous Device Closure of Patent Foramen Ovale in Patients With Presumed Cryptogenic Stroke or Transient Ischemic Attack

Guy Reeder, Donald Hagler

JACC: Cardiovascular Interventions, 2009

View PDFchevron_right

732 Percutaneous closure of patent foramen ovale: head-to-head comparison of two different devices

Alain Delabays

European Heart Journal, 2003

View PDFchevron_right

Amplatzer PFO Occluder Device may Prevent Recurrent Stroke in Patients with Patent Foramen Ovale and Cryptogenic Stroke: A Meta-Analysis of Randomised Trials

Leena Jalota

Heart, Lung and Circulation, 2014

View PDFchevron_right

Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis

Claudia Cagnetti

Cerebrovascular Diseases, 2018

View PDFchevron_right

Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies

Marilena Di Salvo

EuroIntervention, 2014

View PDFchevron_right

Patent foramen ovale closure in non-lacunar cryptogenic ischemic stroke: where are we now?

Adrià Arboix

Journal of Geriatric Cardiology : JGC, 2021

View PDFchevron_right